EQ HEALTH ACQUISITION CORP - *W EXP 02/02/202 (EQHAW)

CUSIP: 26886A119

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / *W EXP 02/02/202
Total 13F shares
5,702,180
Share change
+1,168,340
Total reported value
$3,428,000
Price per share
$0.52
Number of holders
50
Value change
+$604,719
Number of buys
13
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 26886A119?
CUSIP 26886A119 identifies EQHAW - EQ HEALTH ACQUISITION CORP - *W EXP 02/02/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EQ HEALTH ACQUISITION CORP - *W EXP 02/02/202 (EQHAW) as of Q4 2021

As of 31 Dec 2021, EQ HEALTH ACQUISITION CORP - *W EXP 02/02/202 (EQHAW) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,702,180 shares. The largest 10 holders included GLAZER CAPITAL, LLC, Periscope Capital Inc., Shaolin Capital Management LLC, K.J. Harrison & Partners Inc, UBS OCONNOR LLC, INHERENT GROUP, LP, Davidson Kempner Capital Management LP, CITADEL ADVISORS LLC, PEAK6 Investments LLC, and Arena Capital Advisors, LLC- CA. This page lists 50 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.